Form 4 for OMCL OMNICELL, INC.
Accepted 2026-03-17 00:00:00 ET · period of report 2026-03-15 · accession 0001227556-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-17 | 2026-03-15 | OMCL | LIPPS RANDALL A | COB, Pres AND CEO, Dir | A - Grant | $0.00 | +79.5K | 460.2K | +21% | $0 | |
| 2026-03-17 | 2026-03-15 | OMCL | LIPPS RANDALL A | COB, Pres AND CEO, Dir | F - Tax | $34.40 | -15.6K | 444.6K | -3% | -$538.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-15 | A | A | 79,494 | $0.00 | 460,234.07 | D | — | — | (F1) Reflects performance-based restricted stock units that were previously granted on March 15, 2025, subject to the Company meeting certain stock performance objectives compared to the S&P 1000 Healthcare Index. On March 5, 2026 (the determination date), the Compensation Committee determined the performance criteria was met with respect to 79,494 performance-based restricted stock units (100% of target) of which 25% vested upon the one year anniversary of the grant date. The remaining performance-based restricted stock units will vest in equal quarterly increments once every three months over a three-year period (on each May 15, August 15, November 15, and February 15, respectively). |
| 2 | Common | Common Stock | 2026-03-15 | F | D | 15,642 | $34.40 | 444,592.07 | D | — | — | (F2) Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units. |